Current situation of the epidemiology of meningococcal disease;Situación actual de la epidemiología de la enfermedad meningocócica

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 24, Issue SUPPL.1, 2006, Pages 14-18

  Vázquez Moreno, Julio A ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Epidemiology; Meningococcus; Vaccine

Indexed keywords

MENINGOCOCCUS VACCINE;

ARTICLE; BLOOD GROUP TYPING; HUMAN; IMMUNIZATION; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; VACCINATION;

FORECASTING; HUMANS; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS; SEROTYPING; SPAIN;

EID: 34548773356     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1157/13094273     Document Type: Article

References (17)

1. Janda WM, Knapp JS. Neisseria and Moraxella catharralis. En: Murray PR, Baron EJ, Jorgensen JH, Pealler MA, Yolken RH, editors. Manual of clinical microbiology. 2003. Washington: ASM Press; 2003. p. 585-608.
2. Cartwright K. Microbiology and laboratory diagnosis. En: Maiden MCJ, Pollard AJ, editors. Meningococcal disease. Methods and protocols. Totowa: Humana Press; 2001. p. 1-8.
3. Olcen P, Fredlund H. Isolation, culture and identification of meningococci from clinical specimens. En: Maiden MCJ, Pollard AJ, editors. Meningococcal disease. Methods and protocols. Totowa: Humana Press; 2001. p. 9-21.
4. Rosenstein NE, Perkins BA, Stephens DS, Lefkowitz L, Cartter ML, Danila R, et al. The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis. 1999;180:1894-901.
5. Du Chatelet IP, Alonso JM, Taha MK. Clonal expansion of Neisseria meningitidis W135. Epidemiological implications for the african meningitis belt. Bull Soc Pathol Exot. 2002;95:323-4.
6. Alcala B, Salcedo C, Arreaza L, Berron S, De la Fuente L, Vazquez JA. The epidemic wave of meningococcal disease in Spain in 1996-1997: probably, a consequence of strain displacement. J Med Microbiol. 2002;51:1102-6.
7. Salleras L, Domínguez A. Estrategias de vacunación frente al meningococo del serogrupo C en España. Vacunas. 2001;2 Supl 2:10-7.
8. Vázquez JA. Enfermedad meningocócica y vacunación: un nuevo escenario. Vacunas. 2001;2 Supl 2:1-4.
9. Kuipers B, Van den Dobbelsteen G, Wedege E, Van Alphen L. Serological characterization. En: Maiden MCJ, Pollard AJ, editor. Meningococcal disease. Methods and protocols. Totowa: Humana Press; 2001. p. 131-45.
10. Vázquez JA, Marcos C, Berron S. Sero/subtyping of Neisseria meningitidis isolated from patients in Spain. Epidemiol Infect. 1994;113:267-74.
11. Vázquez JA. El desarrollo de vacunas frente a meningococo: un largo, tortuoso y aún inacabado camino. Enferm Infecc Microbiol Clin. 2002;20:313-5.
12. Ramsay ME, Andrews N, Kaczmarski EB, Miller E. Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet. 2000;357:195-6.
13. Cano R, Larrauri A, Mateo S, Alcala B, Salcedo C, Vázquez JA. Impact of the meningococcal C conjugate vaccine in Spain: an epidemiological and microbiological decision. Euro Surveill. 2004;9:11-5.
14. Finne J, Leinonen M, Makela PH. Antigenic similarities between brain components and bacteria causing meningitis: implications for vaccine development and pathogenesis. Lancet. 1983;2 355-7.
15. Ferreirós C, Criado MT, Vázquez J, editors. Emerging strategies in the fight against meningitis. Molecular and cellular aspects. Norfolk: Horizon Scientific Press; 2002.
16. Swartley JS, Marfin AA, Edupuganti S, Liu L-J, Cieslak P, Perkins B, et al. Capsule swiching of Neisseria meningitidis. Proc Natl Acad Sci USA. 1997;94:271-6.
17. Alcalá B, Arreaza L, Salcedo C, Uría MJ, De la Fuente L, Vázquez JA. Capsule switching among C:2b:P1.2,5 meningococcal epidemic strains after mass immunization campaign, Spain. Emerg Infect Dis. 2002;8:1512-4.